STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 71 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $177,000 | +490.0% | 64,053 | +344.8% | 0.00% | – |
| Q3 2020 | $30,000 | -86.1% | 14,401 | -74.8% | 0.00% | -100.0% |
| Q2 2020 | $216,000 | +8.5% | 57,235 | -45.9% | 0.00% | 0.0% |
| Q1 2020 | $199,000 | +97.0% | 105,719 | +116.4% | 0.00% | – |
| Q4 2019 | $101,000 | +274.1% | 48,849 | +336.9% | 0.00% | – |
| Q3 2019 | $27,000 | +285.7% | 11,180 | +416.6% | 0.00% | – |
| Q2 2019 | $7,000 | -84.1% | 2,164 | -75.3% | 0.00% | – |
| Q1 2019 | $44,000 | -62.4% | 8,776 | -48.2% | 0.00% | -100.0% |
| Q3 2017 | $117,000 | +11600.0% | 16,955 | +4609.7% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 360 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 360 | -36.2% | 0.00% | – |
| Q2 2016 | $2,000 | -66.7% | 564 | -58.9% | 0.00% | – |
| Q1 2016 | $6,000 | -40.0% | 1,373 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | – | 1,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |